ALGN Align Technology, Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026ALGN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
ALGN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Align Technology, Inc. - Common Stock Company overview from Wikipedia
Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth.
Invisalign
Invisalign is a brand of clear aligners manufactured by Align Technology. The clear align system had been used to treat more than 18 million patients by 2017, and 22 million patients by 2026.
Align Technology founder Zia Chishti conceived of the basic design of Invisalign while an adult orthodontics patient. During his treatment with a retainer intended to complete his treatment, he posited that a series of such devices could effect a large final placement in a series of small movements. He partnered with Kelsey Wirth to seek developers.
Invisalign was approved by the Food and Drug Administration in 1998, and sales began in the U.S. in 1999. Orthodontists were resistant to adopting Invisalign at first, in particular because the founders had no orthodontic credentials or expertise, but the product became popular among consumers. The company raised about $140 million in funding over four rounds from 1997 to 2000. In 2000 Align Technology planned a $31 million television advertising campaign that The New York Times said would be "the most aggressive consumer advertising plan the dental profession has ever seen". In 2001, $130 million in additional funding was raised through an initial public offering on NASDAQ. By 2001, 75 percent of the 8,500 orthodontists in North America had been trained on the Invisalign system. That same year, Align Technology made Invisalign available to general dentists following a class-action lawsuit that alleged making the system available only to orthodontists resulted in unfair competition for dentists.
In the early 2000s, Align Technology was spending nearly all of its revenues on marketing and advertising, and losing about $18 million per year. Cofounders Wirth and Chishti resigned from Align Technology in 2001 and 2003 respectively, with Thomas Prescott replacing Chishti as CEO in March 2002. Prescott re-focused the company on North America and cut the marketing budget to about one-third its original size.
The Invisalign system grew from 80,000 patients in 2002 to 175,000 in 2004. It won several awards for stereolithography, medical design and fast growth. Align Technology was profitable for the first time in 2003. In 2005 the company expanded into Japan, and acquired General Orthodontic, an orthodontics firm that supported doctors prescribing the Invisalign system. Later that year, the Harvard School of Dental Medicine began requiring that its orthodontic graduate students complete Invisalign certification before they graduate.
The Invisalign Express 10, which uses 10 aligners, was introduced in 2005. Invisalign 1.5 was released in 2009. It was followed by Invisalign G3 in 2010 and G4 in 2011. Invisalign G3 and G4 were designed for more complex treatments. An Invisalign Express 5 version, which uses 5 aligners, was introduced in 2012. In February 2014, Align Technology released a G5 product designed to treat deep bites.
Support, software engineering, pre-production and administrative functions are done from Align Technology's headquarters in California. The manufacturing of Invisalign aligners is performed in Mexico, and treatment plans are created in Costa Rica. Align Technology also operates separate subsidiaries in Hong Kong and Australia that sell Invisalign in their respective markets. Align Technology provides training and certification to doctors.
In 2007 the Academy of General Dentistry approved Align Technology's Program Approval for Continuing Education (PACE) program. The company also created the AlignTech Institute, which provides educational resources to doctors. In March 2011 Align Technology acquired Cadent System, Inc., a dentist firm, for $190 million.
A major revision to the manufacturing process was started in 2026, a switch from mold-based appliance manufacture to 3D-printing, aimed at reducing the cost and complexity of the manufacturing process through disintermediation.
History
Align Technology was founded in 1997 by Zia Chishti and Kelsey Wirth, classmates at Stanford Graduate School of Business, and began working on the development of a clear aligner. Align received FDA clearance to market the Invisalign system in 1998, and it was first marketed in 2000. Align Technology went public on January 26, 2001, on the Nasdaq Stock Market.
In March 2011 Align acquired the Israeli company Cadent for $190 million; Cadent manufactured intraoral scanners that included 3D imaging, as well as software to display the acquired images and to plan treatment.
Joseph M. Hogan joined Align in June 2015, and is CEO and president.
The company's sales reached $1 billion for the first time in 2016 and its products were being used in about 8% of people who got braces. In 2017 the company was faced with the challenge of the expiration of its patents on its Invisalign system starting in October 2017 and the beginning of generic competition.
In March 2020, Align Technology announced that it has signed a definitive agreement to acquire exocad Global Holdings for approximately $418.7 million.
As of February 2023, Align Technology has assisted over 234,000 doctors and over 14.5 million patients worldwide.
In September 2023, it was announced Align Technology had acquired the Vienna-headquartered 3D printing technology and materials company, Cubicure GmbH.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ALGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 25.05Y avg ≈45.1 | ≈45.1 | 28.5 | Overvalued | |
| P/S (TTM) | 2.55Y avg ≈5.9 | ≈5.9 | 2.1 | Overvalued | |
| P/B (MRQ) | 2.45Y avg ≈6.2 | ≈6.2 | 2.1 | Overvalued | |
| Price / FCF (TTM) | 16.25Y avg ≈41.4 | ≈41.4 | · | · | |
| Price / Cash Flow (TTM) | 13.65Y avg ≈27.7 | ≈27.7 | 17.6 | Overvalued | |
| Price / Tangible Book (MRQ) | 2.55Y avg ≈7.3 | ≈7.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ALGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 68.0%5Y avg ≈70.4% | ≈70.4% | 58.2% | Top tier | |
| Operating Margin (TTM) | 13.2%5Y avg ≈17.5% | ≈17.5% | 11.8% | Top tier | |
| EBITDA Margin (TTM) | 19.4%5Y avg ≈21.3% | ≈21.3% | 17.6% | In line | |
| Pretax Margin (TTM) | 13.7%5Y avg ≈17.6% | ≈17.6% | 10.1% | Top tier | |
| Net Profit Margin (TTM) | 10.0%5Y avg ≈12.3% | ≈12.3% | 6.7% | Top tier | |
| ROA (TTM) | 6.5%5Y avg ≈8.2% | ≈8.2% | 3.5% | Top tier | |
| ROE (TTM) | 10.2%5Y avg ≈12.9% | ≈12.9% | 6.5% | Top tier | |
| ROIC | 9.4%5Y avg ≈12.8% | ≈12.8% | 5.1% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ALGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.45Y avg ≈1.3 | ≈1.3 | 1.7 | Low liquidity | |
| Quick Ratio | 1.15Y avg ≈1.0 | ≈1.0 | 0.5 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ALGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 0.90%5Y avg ≈12.4% | ≈12.4% | · | · | |
| Revenue CAGR 3Y | 2.6%5Y avg ≈6.3% | ≈6.3% | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | |
| EPS YoY | 0.53%5Y avg ≈-17.2% | ≈-17.2% | · | · | |
| Net Income YoY | -2.6%5Y avg ≈-18.9% | ≈-18.9% | · | · | |
| EPS CAGR 3Y | 7.0%5Y avg ≈-15.3% | ≈-15.3% | · | · | |
| EPS CAGR 5Y | -24.1% | · | · | · | |
| Net Income CAGR 3Y | 4.3%5Y avg ≈-17.0% | ≈-17.0% | · | · | |
| Net Income CAGR 5Y | -25.4% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ALGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.65Y avg ≈0.7 | ≈0.7 | 0.6 | In line | |
| Inventory Turnover | 5.55Y avg ≈4.6 | ≈4.6 | 2.7 | Top tier | |
| Receivables Turnover | 3.85Y avg ≈4.4 | ≈4.4 | 7.7 | Weak | |
| Revenue / Employee | ≈$197.5K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 29, 2026 | $2.64 | $2.66 | -0.87% |
| March 31, 2026 | $2.58 | $2.33 | 11.0% | |
| Dec. 31, 2025 | $3.29 | $3.03 | 8.5% | |
| Sept. 30, 2025 | $2.61 | $2.45 | 6.5% | |
| June 30, 2025 | $2.49 | $2.62 | -5.0% | |
| March 31, 2025 | $2.13 | $2.02 | 5.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B | $845M | $762M | |
| Cost of Revenue | $1.32B | $1.20B | $1.16B | $1.10B | $1.02B | $709M | $663M | $519M | $356M | $265M | $205M | $183M | |
| Gross Profit | $2.71B | $2.80B | $2.71B | $2.63B | $2.94B | $1.76B | $1.74B | $1.45B | $1.12B | $815M | $640M | $578M | |
| R&D Expense | $370M | $364M | $347M | $305M | $250M | $175M | $157M | $129M | $98M | $76M | $61M | $53M | |
| SG&A Expense | $1.76B | $1.76B | $1.70B | $1.67B | $1.71B | $1.20B | $1.07B | $852M | · | · | $390M | $332M | |
| Operating Expenses | $2.17B | $2.19B | $2.06B | $1.99B | $1.96B | $1.38B | $1.20B | $981M | $763M | $566M | $451M | $385M | |
| Operating Income | $546M | $608M | $643M | $643M | $976M | $387M | $542M | $467M | $354M | $249M | $189M | $194M | |
| Interest Income | · | · | · | · | · | · | $12M | $9M | $7M | $4M | · | · | |
| Other Non-op | $23M | $-19M | $-19M | $-49M | $33M | $-11M | $8M | $-8M | $4M | $-11M | $-3M | $-3M | |
| Pretax Income | $585M | $609M | $641M | $599M | $1.01B | $379M | $563M | $467M | $365M | $243M | $186M | $190M | |
| Income Tax | $175M | $188M | $196M | $237M | $240M | $-1.40B | $112M | $58M | $130M | $51M | $42M | $45M | |
| Net Income | $410M | $421M | $445M | $362M | $772M | $1.78B | $443M | $400M | $231M | $190M | $144M | $146M | |
| EPS (Basic) | $5.66 | $5.63 | $5.82 | $4.62 | $9.78 | $22.55 | $5.57 | $5.00 | $2.89 | $2.38 | $1.80 | $1.81 | |
| EPS (Diluted) | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 | |
| Shares (Basic) | 72,542,000 | 74,877,000 | 76,426,000 | 78,190,000 | 78,917,000 | 78,760,000 | 79,424,000 | 80,064,000 | 80,085,000 | 79,856,000 | 79,998,000 | 80,754,000 | |
| Shares (Diluted) | 72,588,000 | 74,993,000 | 76,568,000 | 78,420,000 | 79,670,000 | 79,230,000 | 80,100,000 | 81,357,000 | 81,832,000 | 81,484,000 | 81,521,000 | 82,283,000 | |
| EBITDA | $783M | $753M | $786M | $768M | $1.09B | $481M | $621M | $521M | $391M | $273M | $207M | $211M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.09B | $1.04B | $937M | $942M | $1.10B | $961M | $550M | $637M | $450M | $389M | $168M | $200M | |
| Short-term Investments | · | · | · | · | · | · | $318M | $98M | $272M | $251M | $360M | $255M | |
| Receivables | $1.10B | $996M | $903M | $860M | $897M | $658M | $550M | $439M | $324M | $247M | $159M | $130M | |
| Inventory | $226M | $254M | $297M | $339M | $230M | $139M | $112M | $56M | $32M | $27M | $19M | $16M | |
| Prepaid Expense | $166M | $199M | $274M | $226M | $195M | $92M | $102M | $72M | $81M | $38M | $27M | $20M | |
| Other Current Assets | $47M | $82M | $77M | $17M | $31M | $62M | $24M | $7M | · | · | · | · | |
| Current Assets | $2.62B | $2.49B | $2.45B | $2.42B | $2.49B | $1.85B | $1.63B | $1.30B | $1.16B | $953M | $732M | $657M | |
| PP&E (Net) | $1.13B | $1.27B | $1.29B | $1.23B | $1.08B | $735M | $632M | $521M | $349M | $175M | $136M | $90M | |
| PP&E (Gross) | $1.90B | $1.93B | $1.84B | $1.68B | $1.44B | $1.04B | $861M | $693M | $485M | $311M | $255M | $198M | |
| Accum. Depreciation | $767M | $662M | $551M | $450M | $359M | $301M | $230M | $172M | $136M | $136M | $118M | $108M | |
| Goodwill | $492M | $443M | $420M | $408M | $419M | $445M | $64M | $64M | $65M | $61M | $61M | $61M | |
| Intangibles | $94M | $103M | $82M | $96M | $110M | $130M | $12M | $18M | $24M | $21M | $18M | $21M | |
| Other Non-current Assets | $278M | $234M | $129M | $56M | $58M | $35M | $40M | $27M | $44M | $13M | $8M | $8M | |
| Total Assets | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B | $4.83B | $2.50B | $2.05B | $1.78B | $1.40B | $1.16B | $988M | |
| Accounts Payable | $121M | $109M | $113M | $128M | $164M | $142M | $87M | $64M | $37M | $29M | $34M | $23M | |
| Accrued Liabilities | $537M | $598M | $526M | $454M | $607M | $406M | $320M | $235M | $196M | $134M | $108M | $88M | |
| Current Liabilities | $1.92B | $2.04B | $2.07B | $1.93B | $1.92B | $1.33B | $971M | $692M | $500M | $354M | $272M | $202M | |
| Capital Leases | $83M | $88M | $97M | $100M | $103M | $64M | $43M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $114M | $140M | $173M | $196M | $175M | $100M | $37M | $29M | $16M | $1M | $2M | $3M | |
| Total Liabilities | $2.18B | $2.36B | $2.45B | $2.35B | $2.32B | $1.60B | $1.15B | $800M | $630M | $401M | $311M | $235M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | |
| Paid-in Capital | $1.51B | $1.36B | $1.16B | $1.04B | $999M | $975M | $907M | $878M | $886M | $865M | $822M | $783M | |
| Retained Earnings | $2.46B | $2.48B | $2.45B | $2.57B | $2.62B | $2.22B | $440M | $378M | $267M | $131M | $27M | $-31M | |
| AOCI | $75M | $6M | $21M | $-10M | $4M | $44M | $-688.0K | $-3M | $571.0K | $-938.0K | $-980.0K | $-140.0K | |
| Stockholders' Equity | $4.05B | $3.85B | $3.63B | $3.60B | $3.62B | $3.23B | $1.35B | $1.25B | $1.15B | $999M | $848M | $753M | |
| Liabilities + Equity | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B | $4.83B | $2.50B | $2.05B | $1.78B | $1.40B | $1.16B | $988M | |
| Shares Outstanding | 71,364,000 | 73,849,000 | 75,075,000 | 77,267,000 | 78,710,000 | 78,860,000 | 78,433,000 | 79,778,000 | 80,040,000 | 79,553,000 | 79,500,000 | 80,205,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $237M | $145M | $142M | $126M | $109M | $94M | $79M | $55M | $38M | $24M | $18M | $18M | |
| Stock-based Comp | $186M | $174M | $154M | $133M | $114M | $98M | $88M | $71M | $59M | $54M | $53M | $40M | |
| Deferred Tax | $33M | $26M | $-19M | $-39M | $15M | $-1.49B | $307.0K | $-16M | $18M | $-16M | $-11M | $4M | |
| Amort. of Intangibles | $19M | $19M | $16M | $16M | $17M | $13M | $6M | $6M | $6M | $3M | · | · | |
| Restructuring | · | $37M | $14M | $10M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-274M | $-28M | $63M | $-13M | $162M | $186M | $137M | $45M | $93M | $-4M | $34M | $-2M | |
| Operating Cash Flow | $593M | $738M | $786M | $569M | $1.17B | $662M | $747M | $555M | $439M | $248M | $238M | $227M | |
| CapEx | $102M | $116M | $178M | $292M | $401M | $155M | $150M | $223M | $196M | $71M | $53M | $24M | |
| Investing Cash Flow | $-112M | $-255M | $-196M | $-213M | $-563M | $-232M | $-350M | $7M | $-251M | $73M | $-166M | $-202M | |
| Stock Issued | $22M | $25M | $27M | $26M | $26M | $20M | $18M | $17M | $14M | $14M | $11M | $18M | |
| Stock Repurchased | $466M | $353M | $592M | $435M | $375M | $0 | $400M | $300M | $104M | $96M | $102M | $98M | |
| Net Stock Activity | $-444M | $-328M | $-566M | $-409M | $-349M | $20M | $-382M | $-283M | $-89M | $-82M | $-90M | $-80M | |
| Financing Cash Flow | $-465M | $-356M | $-598M | $-502M | $-458M | $-31M | $-486M | $-369M | $-136M | $-96M | $-101M | $-66M | |
| Net Change in Cash | $51M | $106M | $-4M | $-158M | $139M | $410M | $-86M | $187M | $57M | $222M | $-32M | $-43M | |
| Taxes Paid | $135M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $491M | $623M | $608M | $277M | $771M | $507M | $598M | $331M | $243M | $177M | $185M | $203M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% | 71.3% | 72.5% | 73.6% | 75.8% | 75.5% | 75.7% | 75.9% | |
| Operating Margin | 13.5% | 15.2% | 16.7% | 17.2% | 24.7% | 15.7% | 22.5% | 23.7% | 24.0% | 23.1% | 22.3% | 25.4% | |
| Net Margin | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% | 18.4% | 20.3% | 15.7% | 17.6% | 17.0% | 19.1% | |
| Pretax Margin | 14.5% | 15.2% | 16.6% | 16.0% | 25.6% | 15.3% | 23.4% | 23.7% | 24.8% | 22.5% | 22.0% | 25.0% | |
| EBITDA Margin | 19.4% | 18.8% | 20.3% | 20.6% | 27.5% | 19.4% | 25.8% | 26.5% | 26.6% | 25.3% | 24.4% | 27.8% | |
| ROA | 6.6% | 6.9% | 7.4% | 6.1% | 14.3% | 48.4% | 19.4% | 20.9% | 14.6% | 14.8% | 13.4% | 16.0% | |
| ROE | 10.3% | 10.8% | 12.0% | 9.9% | 21.6% | 56.7% | 33.4% | 32.7% | 21.5% | 20.6% | 18.0% | 21.0% | |
| ROIC | 9.4% | 10.9% | 12.3% | 10.8% | 20.5% | 56.1% | 32.2% | 32.6% | 19.8% | 19.7% | 17.2% | 19.7% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | 1.7 | 1.9 | 2.3 | 2.7 | 2.7 | 3.3 | |
| Quick Ratio | 1.1 | 1.0 | 0.9 | 0.9 | 1.0 | 1.2 | 1.5 | 1.7 | 2.1 | 2.5 | 2.5 | 2.9 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | |
| Inventory Turnover | 5.5 | 4.4 | 3.6 | 3.9 | 5.5 | 5.6 | 7.9 | 11.9 | 12.1 | 11.4 | 11.6 | 12.3 | |
| Receivables Turnover | 3.8 | 4.2 | 4.4 | 4.3 | 5.1 | 4.1 | 4.9 | 5.2 | 5.2 | 5.3 | 5.9 | 6.3 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $56.74 | $52.16 | $48.36 | $46.61 | $46.03 | $41.01 | $17.16 | $15.70 | $14.37 | $12.51 | $10.67 | $9.39 | |
| Revenue / Share | $55.59 | $53.33 | $50.44 | $47.62 | $49.61 | $31.20 | $30.05 | $24.17 | $18.01 | $13.25 | $10.37 | $9.26 | |
| Cash Flow / Share | $8.17 | $9.84 | $10.26 | $7.25 | $14.72 | $8.36 | $9.33 | $6.82 | $5.36 | $3.04 | $2.92 | $2.76 | |
| Cash / Share | $15.34 | $14.14 | $12.49 | $12.19 | $13.97 | $12.18 | $7.02 | $7.98 | $5.62 | $4.89 | $2.11 | $2.49 | |
| EPS (TTM) | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.90% | 3.5% | 3.4% | -5.5% | 59.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.6% | 0.39% | 16.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 0.53% | -3.3% | 26.0% | -52.4% | -56.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 7.0% | -16.6% | -36.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -24.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -2.6% | -5.3% | 23.1% | -53.2% | -56.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 4.3% | -18.3% | -37.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -25.4% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B | $845M | $762M | |
| Net Income TTM | $410M | $421M | $445M | $362M | $772M | $1.78B | $443M | $400M | $231M | $190M | $144M | $146M | |
| Market Cap | $11.14B | $15.40B | $20.57B | $16.30B | $51.73B | $42.14B | $21.89B | $16.71B | $17.78B | $7.65B | $5.24B | $4.48B | |
| P/E | 27.6 | 37.1 | 47.2 | 45.7 | 67.8 | 23.8 | 50.5 | 42.6 | 78.5 | 41.3 | 37.2 | 31.6 | |
| P/S | 2.8 | 3.9 | 5.3 | 4.4 | 13.1 | 17.0 | 9.1 | 8.5 | 12.1 | 7.1 | 6.2 | 5.9 | |
| P/B | 2.8 | 4.0 | 5.7 | 4.5 | 14.3 | 13.0 | 16.3 | 13.3 | 15.5 | 7.7 | 6.2 | 6.0 | |
| P / Tangible Book | 3.2 | 4.7 | 6.6 | 5.3 | 16.7 | 15.8 | · | · | · | · | · | · | |
| P / Cash Flow | 18.8 | 20.9 | 26.2 | 28.7 | 44.1 | 63.6 | 29.3 | 30.1 | 40.6 | 30.9 | 22.0 | 19.8 | |
| P / FCF | 22.7 | 24.7 | 33.8 | 58.9 | 67.1 | 83.1 | 36.6 | 50.4 | 73.2 | 43.2 | 28.4 | 22.1 | |
| Earnings Yield | 3.6% | 2.7% | 2.1% | 2.2% | 1.5% | 4.2% | 2.0% | 2.4% | 1.3% | 2.4% | 2.7% | 3.2% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.06B | $1.04B | $1.05B | $996M | $1.01B | $979M | $995M | $978M | $1.03B | $997M | $957M | $960M | $1.00B | $943M | $902M | $890M | |
| Cost of Revenue | $299M | $304M | $364M | $356M | $304M | $299M | $298M | $296M | $306M | $300M | $287M | $297M | $289M | $282M | $284M | $271M | |
| Gross Profit | $757M | $737M | $684M | $639M | $708M | $680M | $697M | $682M | $723M | $698M | $670M | $663M | $714M | $661M | $618M | $619M | |
| R&D Expense | $102M | $99M | $83M | $93M | $96M | $97M | $95M | $85M | $92M | $92M | $82M | $89M | $88M | $87M | $84M | $77M | |
| SG&A Expense | $463M | $465M | $442M | $418M | $449M | $448M | $425M | $434M | $452M | $452M | $403M | $408M | $453M | $440M | $410M | $399M | |
| Operating Expenses | $603M | $595M | $528M | $543M | $545M | $549M | $553M | $519M | $576M | $544M | $498M | $497M | $542M | $527M | $505M | $476M | |
| Operating Income | $154M | $142M | $155M | $96M | $163M | $131M | $144M | $162M | $147M | $154M | $172M | $166M | $172M | $134M | $113M | $144M | |
| Other Non-op | $-10M | $3M | $17M | $-5M | $8M | $4M | $-12M | $-371.0K | $-6M | $-141.0K | $-4M | $-10M | $-5M | $-1M | $-100.0K | $-23M | |
| Pretax Income | $149M | $149M | $177M | $95M | $174M | $140M | $141M | $166M | $144M | $158M | $173M | $162M | $172M | $135M | $115M | $123M | |
| Income Tax | $40M | $36M | $41M | $38M | $49M | $47M | $37M | $50M | $47M | $53M | $49M | $41M | $60M | $47M | $74M | $50M | |
| Net Income | $108M | $113M | $136M | $57M | $125M | $93M | $104M | $116M | $97M | $105M | $124M | $121M | $112M | $88M | $42M | $73M | |
| EPS (Basic) | $1.51 | $1.58 | $1.89 | $0.78 | $1.72 | $1.27 | $1.40 | $1.55 | $1.28 | $1.40 | $1.63 | $1.59 | $1.46 | $1.14 | $0.54 | $0.93 | |
| EPS (Diluted) | $1.51 | $1.57 | $1.88 | $0.78 | $1.72 | $1.27 | $1.40 | $1.55 | $1.28 | $1.39 | $1.63 | $1.58 | $1.46 | $1.14 | $0.54 | $0.93 | |
| Shares (Basic) | 71,495,000 | 71,425,000 | · | 72,377,000 | 72,565,000 | 73,562,000 | · | 74,736,000 | 75,184,000 | 75,175,000 | · | 76,569,000 | 76,524,000 | 76,921,000 | · | 78,093,000 | |
| Shares (Diluted) | 71,520,000 | 71,614,000 | · | 72,419,000 | 72,593,000 | 73,615,000 | · | 74,757,000 | 75,223,000 | 75,322,000 | · | 76,826,000 | 76,689,000 | 77,111,000 | · | 78,237,000 | |
| EBITDA | $194M | $199M | · | $152M | $204M | $170M | · | $200M | $183M | $187M | · | $203M | $208M | $169M | · | $176M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.06B | $1.09B | $1.00B | $901M | $873M | $1.04B | $1.04B | $761M | $866M | · | $1.24B | $952M | $832M | · | $1.04B | |
| Receivables | $1.15B | $1.13B | $1.10B | $1.10B | $1.12B | $1.06B | $996M | $1.01B | $1.02B | $951M | · | $904M | $908M | $884M | · | $860M | |
| Inventory | $212M | $215M | $226M | $228M | $244M | $247M | $254M | $254M | $259M | $280M | · | $296M | $313M | $312M | · | $321M | |
| Prepaid Expense | $200M | $216M | $166M | $174M | $187M | $220M | $199M | $291M | $351M | $350M | · | $218M | $237M | $252M | · | $229M | |
| Other Current Assets | $52M | $57M | $47M | $57M | $57M | $83M | $82M | $69M | $71M | $70M | · | $34M | $23M | $23M | · | $47M | |
| Current Assets | $2.66B | $2.66B | $2.62B | $2.53B | $2.45B | $2.40B | $2.49B | $2.60B | $2.41B | $2.48B | · | $2.70B | $2.47B | $2.33B | · | $2.50B | |
| PP&E (Net) | $1.11B | $1.11B | $1.13B | $1.18B | $1.26B | $1.26B | $1.27B | $1.29B | $1.28B | $1.28B | · | $1.27B | $1.28B | $1.26B | · | $1.20B | |
| PP&E (Gross) | · | · | $1.90B | · | · | · | $1.93B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $767M | · | · | · | $662M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $497M | $503M | $492M | $492M | $491M | $458M | $443M | $472M | $454M | $458M | $420M | $404M | $415M | $414M | $408M | $378M | |
| Intangibles | $95M | $101M | $94M | $99M | $103M | $103M | $103M | $116M | $116M | $121M | · | $83M | $89M | $93M | · | $92M | |
| Other Non-current Assets | $453M | $365M | $278M | $254M | $251M | $239M | $234M | $200M | $198M | $122M | · | $132M | $138M | $54M | · | $52M | |
| Total Assets | $6.42B | $6.31B | $6.23B | $6.23B | $6.22B | $6.10B | $6.21B | $6.37B | $6.16B | $6.16B | · | $6.32B | $6.14B | $5.90B | · | $5.91B | |
| Accounts Payable | $110M | $124M | $121M | $126M | $114M | $125M | $109M | $109M | $106M | $117M | · | $100M | $110M | $131M | · | $139M | |
| Accrued Liabilities | $612M | $547M | $537M | $546M | $563M | $546M | $598M | $575M | $555M | $497M | · | $614M | $600M | $497M | · | $384M | |
| Current Liabilities | $1.91B | $1.91B | $1.92B | $1.97B | $2.00B | $1.99B | $2.04B | $2.06B | $2.04B | $2.02B | · | $2.12B | $2.11B | $2.00B | · | $1.81B | |
| Capital Leases | $87M | $83M | $83M | $87M | $90M | $86M | $88M | $96M | $98M | $95M | · | $99M | $105M | $99M | · | $97M | |
| Other Non-current Liabilities | $120M | $108M | $114M | $112M | $117M | $131M | $140M | $150M | $158M | $156M | · | $179M | $181M | $191M | · | $185M | |
| Total Liabilities | $2.19B | $2.16B | $2.18B | $2.28B | $2.31B | $2.31B | $2.36B | $2.42B | $2.40B | $2.40B | · | $2.52B | $2.51B | $2.42B | · | $2.22B | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | · | $8.0K | $8.0K | $8.0K | · | $8.0K | |
| Paid-in Capital | $1.57B | $1.53B | $1.51B | $1.48B | $1.43B | $1.39B | $1.36B | $1.34B | $1.28B | $1.24B | · | $1.19B | $1.14B | $1.10B | · | $1.06B | |
| Retained Earnings | $2.60B | $2.55B | $2.46B | $2.42B | $2.43B | $2.39B | $2.48B | $2.57B | $2.46B | $2.50B | · | $2.61B | $2.49B | $2.37B | · | $2.67B | |
| AOCI | $67M | $70M | $75M | $65M | $61M | $18M | $6M | $36M | $25M | $18M | · | $2M | $11M | $2M | · | $-41M | |
| Stockholders' Equity | $4.23B | $4.15B | $4.05B | $3.96B | $3.91B | $3.79B | $3.85B | $3.94B | $3.76B | $3.76B | $3.63B | $3.80B | $3.64B | $3.48B | $3.60B | $3.69B | |
| Liabilities + Equity | $6.42B | $6.31B | $6.23B | $6.23B | $6.22B | $6.10B | $6.21B | $6.37B | $6.16B | $6.16B | · | $6.32B | $6.14B | $5.90B | · | $5.91B | |
| Shares Outstanding | 71,245,000 | 71,617,000 | 71,364,000 | 72,040,000 | 72,486,000 | 73,057,000 | 73,849,000 | 74,757,000 | 74,696,000 | 75,281,000 | · | 76,588,000 | 76,532,000 | 76,516,000 | · | 78,111,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $57M | $102M | $56M | $41M | $39M | $38M | $38M | $36M | $33M | $34M | $37M | $36M | $36M | $34M | $32M | |
| Stock-based Comp | $46M | $41M | $44M | $48M | $48M | $45M | $39M | $49M | $47M | $39M | $39M | $40M | $38M | $38M | $35M | $33M | |
| Deferred Tax | $-9M | $41M | $42M | $-9M | $-34M | $34M | $8M | $8M | $-9M | $18M | $4M | $14M | $-18M | $-18M | $-46M | $-8M | |
| Amort. of Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Restructuring | · | · | · | $32M | $-100.0K | $2M | $37M | $0 | $-357.0K | $14M | $14M | · | $100.0K | $10M | $10M | · | |
| Other Non-cash | · | $-100M | · | · | · | $-158M | · | · | · | $-166M | · | · | · | $57M | · | · | |
| Operating Cash Flow | $193M | $151M | $223M | $189M | $129M | $53M | $286M | $264M | $160M | $29M | $47M | $287M | $252M | $200M | $145M | $266M | |
| CapEx | $36M | $31M | $36M | $20M | $21M | $25M | $23M | $30M | $53M | $9M | $33M | $22M | $59M | $64M | $53M | $75M | |
| Investing Cash Flow | $-82M | $-132M | $-36M | $-20M | $-31M | $-25M | $-54M | $-9M | $-112M | $-80M | $-13M | $-4M | $-125M | $-53M | $-56M | $-85M | |
| Stock Issued | $0 | $12M | $0 | $8M | $0 | $14M | $0 | $11M | $0 | $14M | $0 | $12M | $0 | $14M | $0 | $11M | |
| Stock Repurchased | $67M | $31M | $97M | $72M | $96M | $201M | $203M | $0 | $150M | $0 | $300M | $0 | $0 | $292M | $160M | $0 | |
| Net Stock Activity | · | $-19M | · | · | · | $-187M | · | · | · | $14M | · | · | · | $-278M | · | · | |
| Financing Cash Flow | $-67M | $-48M | $-97M | $-64M | $-96M | $-207M | $-203M | $11M | $-152M | $-12M | $-350M | $12M | $-931.0K | $-259M | $-200M | $11M | |
| Net Change in Cash | $43M | $-35M | $90M | $103M | $28M | $-171M | $2M | $281M | $-104M | $-72M | $-301M | $287M | $120M | $-110M | $-102M | $167M | |
| Free Cash Flow | · | $120M | · | · | · | $27M | · | · | · | $19M | · | · | · | $136M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.7% | 70.8% | · | 64.2% | 69.9% | 69.5% | · | 69.7% | 70.3% | 70.0% | · | 69.1% | 71.2% | 70.0% | · | 69.5% | |
| Operating Margin | 14.6% | 13.7% | · | 9.7% | 16.1% | 13.4% | · | 16.6% | 14.3% | 15.4% | · | 17.3% | 17.2% | 14.2% | · | 16.1% | |
| Net Margin | 10.2% | 10.8% | · | 5.7% | 12.3% | 9.5% | · | 11.9% | 9.4% | 10.5% | · | 12.7% | 11.2% | 9.3% | · | 8.2% | |
| Pretax Margin | 14.1% | 14.3% | · | 9.5% | 17.1% | 14.3% | · | 17.0% | 14.0% | 15.9% | · | 16.9% | 17.1% | 14.3% | · | 13.8% | |
| EBITDA Margin | 18.4% | 19.1% | · | 15.3% | 20.1% | 17.4% | · | 20.5% | 17.8% | 18.8% | · | 21.2% | 20.7% | 17.9% | · | 19.8% | |
| ROA | 1.7% | 1.8% | · | 0.90% | 2.0% | 1.5% | · | 1.8% | 1.6% | 1.7% | · | 2.0% | 1.9% | 1.5% | · | 1.3% | |
| ROE | 2.7% | 2.8% | · | 1.4% | 3.2% | 2.5% | · | 3.0% | 2.6% | 2.9% | · | 3.2% | 3.1% | 2.5% | · | 2.0% | |
| ROIC | 2.6% | 2.6% | · | 1.5% | 3.0% | 2.3% | · | 2.9% | 2.6% | 2.7% | · | 3.3% | 3.1% | 2.5% | · | 2.3% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.3 | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.0 | 0.9 | 0.9 | · | 1.0 | 0.9 | 0.9 | · | 1.1 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 1.3 | 1.3 | · | 1.5 | 1.2 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 1.0 | 0.9 | 1.0 | · | 1.0 | |
| Receivables Turnover | 0.9 | 1.0 | · | 0.9 | 0.9 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 1.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $59.41 | $57.94 | · | $54.93 | $53.98 | $51.94 | · | $52.76 | $50.31 | $49.94 | · | $49.64 | $47.54 | $45.48 | · | $47.30 | |
| Revenue / Share | $14.77 | $14.52 | · | $13.75 | $13.95 | $13.30 | · | $13.08 | $13.67 | $13.24 | · | $12.50 | $13.07 | $12.23 | · | $11.38 | |
| Cash Flow / Share | · | $2.11 | · | · | · | $0.72 | · | · | · | $0.38 | · | · | · | $2.59 | · | · | |
| Cash / Share | $15.48 | $14.80 | · | $13.94 | $12.43 | $11.95 | · | $13.94 | $10.19 | $11.50 | · | $16.18 | $12.44 | $10.88 | · | $13.37 | |
| EPS (TTM) | $5.74 | $5.95 | · | $5.17 | $5.94 | $5.50 | · | $5.85 | $5.88 | $6.06 | · | $4.72 | $4.07 | $4.05 | · | $6.46 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.14B | $4.10B | · | $3.98B | $3.96B | $3.98B | · | $3.96B | $3.94B | $3.92B | · | $3.81B | $3.74B | $3.70B | · | $3.86B | |
| Net Income TTM | $414M | $430M | · | $378M | $438M | $410M | · | $442M | $447M | $462M | · | $363M | $314M | $315M | · | $511M | |
| Market Cap | $12.02B | $12.28B | · | $9.02B | $13.72B | $11.61B | · | $19.01B | $18.03B | $24.69B | · | $23.38B | $27.06B | $25.57B | · | $16.18B | |
| P/E | 29.4 | 28.8 | · | 24.2 | 31.9 | 28.9 | · | 43.5 | 41.1 | 54.1 | · | 64.7 | 86.9 | 82.5 | · | 32.1 | |
| P/S | 2.9 | 3.0 | · | 2.3 | 3.5 | 2.9 | · | 4.8 | 4.6 | 6.3 | · | 6.1 | 7.2 | 6.9 | · | 4.2 | |
| P/B | 2.8 | 3.0 | · | 2.3 | 3.5 | 3.1 | · | 4.8 | 4.8 | 6.6 | · | 6.2 | 7.4 | 7.3 | · | 4.4 | |
| P / Tangible Book | 3.3 | 3.5 | · | 2.7 | 4.1 | 3.6 | · | 5.7 | 5.7 | 7.8 | · | 7.1 | 8.6 | 8.6 | · | 5.0 | |
| P / Cash Flow | · | 81.3 | · | · | · | 220.3 | · | · | · | 861.2 | · | · | · | 127.9 | · | · | |
| Earnings Yield | 3.4% | 3.5% | · | 4.1% | 3.1% | 3.5% | · | 2.3% | 2.4% | 1.8% | · | 1.6% | 1.1% | 1.2% | · | 3.1% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B |
| Gross Margin % | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% |
| Operating Margin % | 13.5% | 15.2% | 16.7% | 17.2% | 24.7% |
| Net Income | $410M | $421M | $445M | $362M | $772M |
| Diluted EPS | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.2 | 1.2 | 1.3 | 1.3 |
| Quick Ratio | 1.1 | 1.0 | 0.9 | 0.9 | 1.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $491M | $623M | $608M | $277M | $771M |
Institutional owners (13F) 750 filers · $13.7B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 72 (-73 vs prior Q) | 81 (-2 vs prior Q) | 215 (-34 vs prior Q) | 289 (+61 vs prior Q) | +3.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1,277,272,490 | 8,179,779 | 9.31% | Shares |
| BlackRock, Inc. | $745,370,304 | 4,419,366 | 5.44% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $742,325,451 | 4,401,313 | 5.41% | Shares |
| FMR LLC | $684,765,036 | 4,060,032 | 4.99% | Shares |
| Capital International Investors | $682,324,318 | 4,045,561 | 4.98% | Shares |
| Capital World Investors | $577,219,454 | 3,422,385 | 4.21% | Shares |
| GOLDMAN SACHS GROUP INC | $568,849,702 | 3,372,760 | 4.15% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $528,203,316 | 3,131,764 | 3.85% | Shares |
| STATE STREET CORP | $431,518,634 | 2,558,512 | 3.15% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $378,153,032 | 2,245,315 | 2.76% | Shares |
| Ninety One UK Ltd | $372,703,280 | 2,209,791 | 2.72% | Shares |
| UBS Group AG | $358,450,738 | 2,125,286 | 2.61% | Shares |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $292,369,455 | 1,733,484 | 2.13% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $242,715,391 | 1,438,900 | 1.77% | Shares |
| Invesco Ltd. | $238,412,210 | 1,413,567 | 1.74% | Shares |
| Ruane, Cunniff & Goldfarb L.P. | $197,577,600 | 1,171,455 | 1.44% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $180,736,225 | 1,071,601 | 1.32% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $180,291,468 | 1,068,964 | 1.31% | Shares |
| MORGAN STANLEY | $170,994,867 | 1,013,842 | 1.25% | Shares |
| NORGES BANK | $152,573,715 | 904,623 | 1.11% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $151,163,848 | 899,731 | 1.10% | Shares |
| JPMORGAN CHASE & CO | $134,654,324 | 773,182 | 0.98% | Shares |
| DISCIPLINED GROWTH INVESTORS INC /MN | $132,090,801 | 783,178 | 0.96% | Shares |
| Senvest Management, LLC | $125,709,888 | 745,345 | 0.92% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $112,686,638 | 668,129 | 0.82% | Shares |
| Swedbank AB | $111,012,012 | 658,200 | 0.81% | Shares |
| BARCLAYS PLC | $108,101,615 | 640,944 | 0.79% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $107,285,353 | 625,826 | 0.78% | Shares |
| Assenagon Asset Management S.A. | $106,450,265 | 631,153 | 0.78% | Shares |
| VOYA INVESTMENT MANAGEMENT LLC | $105,404,604 | 624,952 | 0.77% | Shares |
| DEUTSCHE BANK AG\ | $99,778,582 | 591,596 | 0.73% | Shares |
| NORTHERN TRUST CORP | $94,827,567 | 562,241 | 0.69% | Shares |
| BANK OF AMERICA CORP /DE/ | $93,085,478 | 551,912 | 0.68% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $79,759,314 | 472,900 | 0.58% | Put option |
| FEDERATED HERMES, INC. | $78,222,317 | 463,787 | 0.57% | Shares |
| Bares Capital Management, Inc. | $76,349,389 | 609,722 | 0.56% | Shares |
| Amundi | $73,309,080 | 434,656 | 0.53% | Shares |
| BROWN ADVISORY INC | $69,759,715 | 413,611 | 0.51% | Shares |
| DAVENPORT & Co LLC | $64,891,092 | 384,745 | 0.47% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $63,304,170 | 375,336 | 0.46% | Shares |
| JENNISON ASSOCIATES LLC | $59,641,380 | 353,619 | 0.43% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $59,357,000 | 351,934 | 0.43% | Shares |
| Bank of New York Mellon Corp | $57,062,230 | 338,327 | 0.42% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $56,163,780 | 333,000 | 0.41% | Call option |
| Carmignac Gestion | $53,495,676 | 316,832 | 0.39% | Shares |
| CITADEL ADVISORS LLC | $50,443,170 | 299,082 | 0.37% | Shares |
| Resona Asset Management Co.,Ltd. | $49,583,874 | 291,177 | 0.36% | Shares |
| KEYBANK NATIONAL ASSOCIATION/OH | $47,572,414 | 282,061 | 0.35% | Shares |
| WELLS FARGO & COMPANY/MN | $47,249,188 | 280,145 | 0.34% | Shares |
| Nearwater Capital Markets, Ltd | $45,200,880 | 268,000 | 0.33% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Danaher Corporation ×3 filings | Nov. 14, 2013 | · | Initial filing | Passive investment | SEC |
| 1. Danaher Corporation | Feb. 22, 2011 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 66 insiders · 24 officers · 17 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Joseph M Hogan | President and CEO | Feb. 20, 2026 M | 209,270 | 0 | 0 | $0 |
| John Morici | EVP, CHIEF FINANCIAL OFFICER | Feb. 20, 2026 M | 13,536 | 0 | 1 | $-1,508,611 |
| Kenneth Arola | VP, Finance and CFO | Feb. 20, 2013 C | 31,682 | 0 | 0 | $0 |
| Julie Ann Coletti | EVP, CHIEF LEGAL & REGULATORY | Feb. 20, 2026 M | 11,445 | 0 | 0 | $0 |
| Stuart A Hockridge | EVP, GLOBAL HR | Feb. 20, 2026 M | 14,892 | 0 | 0 | $0 |
| Emory Wright | EVP, GLOBAL OPERATIONS | Feb. 20, 2024 A | 8,294 | 0 | 0 | $0 |
| Jennifer Olson | SVP & Mng Dir Cust Service | Nov. 6, 2020 G | 2,277 | 0 | 0 | $0 |
| Yuval Shaked | SVP & Mng Dir. Itero | Nov. 4, 2020 S | 636 | 0 | 0 | $0 |
| Zelko Relic | SVp, R&D and CTO | Nov. 4, 2020 S | 13,716 | 0 | 0 | $0 |
| Markus Christof Sebstian | SVP & Mng Dir EMEA | Oct. 20, 2020 M | 613 | 0 | 0 | $0 |
| Simon Beard | SVP and Mgng Director, EMEA | Aug. 27, 2020 S | 17,670 | 0 | 0 | $0 |
| Vamsi Mohan Raj Pudipeddi | SVP, Chief Marketing Officer | May 18, 2020 S | 0 | 0 | 0 | $0 |
| Sreelakshmi Kolli | SVP & Mng Dir Info Tech | Feb. 20, 2020 M | 13,409 | 0 | 0 | $0 |
| Raphael Pascaud | CMO & Bus. Dev. | Oct. 1, 2019 M | 27,156 | 0 | 0 | $0 |
| Julie Tay | SVP & Mng Dir. Asia Pacific | May 8, 2019 S | 17,746 | 0 | 0 | $0 |
| Christopher C. Puco | VP, No. American Sales | Nov. 30, 2018 S | 0 | 0 | 0 | $0 |
| Lynn Pendergrass | VP, Americas | March 20, 2017 A | · | 0 | 0 | $0 |
| Timothy A Mack | VP, Bus Dev | Feb. 20, 2016 M | 0 | 0 | 0 | $0 |
| Jennifer Erfurth | VP, Global HR | Feb. 20, 2016 A | 10,760 | 0 | 0 | $0 |
| John Patrick Graham | VP, Mktg & CMO | May 5, 2015 S | 0 | 0 | 0 | $0 |
| Richard M.L. Twomey | VP International | Oct. 30, 2013 M | 4,272 | 0 | 0 | $0 |
| Dana Cambra | VP, R&D | June 18, 2012 C | 4,398 | 0 | 0 | $0 |
| Sheila K Tan | VP Marketing & CMO | Nov. 17, 2011 C | 19,523 | 0 | 0 | $0 |
| Afsaneh Azadeh | Chief Information Officer | Feb. 20, 2008 A | · | 0 | 0 | $0 |
| Quentin S. Blackford | Director | Aug. 27, 2026 A | · | 0 | 0 | $0 |
| Anne Myong | Director | May 20, 2026 A | 9,830 | 0 | 0 | $0 |
| Mojdeh Poul | Director | May 20, 2026 A | 3,553 | 0 | 0 | $0 |
| Kevin J Dallas | Director | May 20, 2026 A | 16,168 | 0 | 0 | $0 |
| Britt J. Vitalone | Director | May 20, 2026 A | 1,443 | 0 | 0 | $0 |
| Andrea Lynn Saia | Director | May 20, 2026 A | 17,318 | 0 | 0 | $0 |
| Kevin T Conroy | Director | May 20, 2026 A | 3,553 | 0 | 0 | $0 |
| Susan E Siegel | Director | May 20, 2026 A | 10,723 | 0 | 0 | $0 |
| Joseph Lacob | Director | May 20, 2026 A | 135,916 | 0 | 0 | $0 |
| MORROW GEORGE J | Director | May 20, 2026 M | 5,036 | 0 | 0 | $0 |
| Raymond C Larkin JR | Director | May 20, 2026 A | 27,454 | 0 | 0 | $0 |
| Warren S Thaler | Director | May 17, 2023 M | 31,780 | 0 | 0 | $0 |
| Greg J Santora | Director | May 17, 2023 M | 11,987 | 0 | 0 | $0 |
| Thomas M Prescott | Director | May 19, 2021 M | 54,129 | 0 | 0 | $0 |
| David E Collins | Director | May 15, 2014 C | 25,900 | 0 | 0 | $0 |
| Brian H Dovey | Director | May 19, 2004 A | 0 | 0 | 0 | $0 |
| DANAHER CORP /DE/ | 10% owner | Nov. 13, 2013 S | 3,837,132 | 0 | 0 | $0 |
| KLEINER PERKINS CAUFIELD & BYERS VIII LP | 10% owner | Nov. 10, 2004 J | 1,492,421 | 0 | 0 | $0 |
| Roger E George | · | May 14, 2019 S | 11,773 | 0 | 0 | $0 |
| David L White | · | Nov. 18, 2016 G | 5,913 | 0 | 0 | $0 |
| David C Nagel | · | May 13, 2016 M | 30,200 | 0 | 0 | $0 |
| Len Hedge | · | Feb. 20, 2013 C | 55,861 | 0 | 0 | $0 |
| Dan Scott Ellis | · | Nov. 19, 2012 M | 3,552 | 0 | 0 | $0 |
| Gil Laks | · | Feb. 24, 2010 C | 9,773 | 0 | 0 | $0 |
| Sonia Clark | · | Sept. 25, 2008 C | 1,806 | 0 | 0 | $0 |
| Darrell Zoromski | · | Aug. 20, 2008 C | 1,647 | 0 | 0 | $0 |
| Kent H Bowen | · | May 15, 2008 C | 84,500 | 0 | 0 | $0 |
| Hossein Arjomand | · | Nov. 26, 2007 C | 617 | 0 | 0 | $0 |
| Eldon M Bullington | · | Nov. 26, 2007 C | 4,967 | 0 | 0 | $0 |
| Michael J Henry | · | May 1, 2007 S | 0 | 0 | 0 | $0 |
| Kelsey Wirth | · | May 2, 2006 S | 1,074,022 | 0 | 0 | $0 |
| David Thrower | · | Aug. 10, 2005 M | 15,980 | 0 | 0 | $0 |
| Brian Dovey | · | May 25, 2005 A | · | 0 | 0 | $0 |
| Rok Sribar | · | March 1, 2005 A | · | 0 | 0 | $0 |
| Robert D Mitchell | · | Feb. 22, 2005 A | · | 0 | 0 | $0 |
| Patricia L Wadors | · | Feb. 22, 2005 A | · | 0 | 0 | $0 |
| Cecilia Claudio | · | Feb. 22, 2005 A | · | 0 | 0 | $0 |
| KPCB VIII ASSOCIATES LP | · | Nov. 10, 2004 J | 86,526 | 0 | 0 | $0 |
| Amir Abolfathi | · | Nov. 8, 2004 M | 10,334 | 0 | 0 | $0 |
| Jon Fjeld | · | May 28, 2004 S | 108,864 | 0 | 0 | $0 |
| Gordon Gund | · | May 10, 2004 P | 68,659 | 0 | 0 | $0 |
| Joe Breeland | · | March 12, 2004 A | 53,985 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 84 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 3.44% | 9,273 NS | July 31, 2026 | N-PORT |
| PRNT · ARK ETF Trust | 1.58% | 5,467 NS | July 31, 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.55% | 93,283 SH | Oct. 1, 2026 | Daily |
| RNIN · EA Series Trust | 1.09% | 11,732 NS | July 31, 2026 | N-PORT |
| ALTL · Pacer Funds Trust | 0.90% | 4,911 NS | July 31, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0.85% | 52,527 NS | July 31, 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0.70% | 376 NS | July 31, 2026 | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 0.63% | 41,430 SH | Oct. 1, 2026 | Daily |
| HIBL · Direxion Shares ETF Trust | 0.61% | 2,712 NS | July 31, 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0.52% | 6,492 NS | July 31, 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.47% | 751 SH | Oct. 1, 2026 | Daily |
| BKMC · BNY Mellon ETF Trust | 0.28% | 10,766 NS | July 31, 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.28% | 235,486 NS | July 31, 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.25% | 30,473 NS | July 31, 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.24% | 990,688 SH | Aug. 19, 2026 | Daily |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 1,279,170 SH | Oct. 1, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.17% | 204,512 SH | Aug. 19, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.17% | 32,382 NS | July 31, 2026 | N-PORT |
| IYH · iShares Trust | 0.16% | 39,100 SH | Sept. 11, 2026 | Daily |
| ISCG · iShares Trust | 0.15% | 9,672 SH | Sept. 11, 2026 | Daily |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.15% | 12,214 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.15% | 133,009 NS | July 31, 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0.15% | 2,860 NS | July 31, 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0.14% | 1,921 NS | July 31, 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.14% | 1,560,504 SH | Aug. 19, 2026 | Daily |
| VFQY · VANGUARD WELLINGTON FUND | 0.14% | 4,009 SH | Aug. 19, 2026 | Daily |
| ESML · iShares Trust | 0.14% | 25,829 SH | Sept. 11, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 0.13% | 1,311 NS | July 31, 2026 | N-PORT |
| IXJ · iShares Trust | 0.13% | 34,914 SH | Sept. 11, 2026 | Daily |
| IWS · iShares Trust | 0.10% | 100,293 SH | Sept. 11, 2026 | Daily |
| PEXL · Pacer Funds Trust | 0.10% | 295 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.10% | 4,205 SH | Sept. 11, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.09% | 32,471 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 5,007 SH | Oct. 1, 2026 | Daily |
| VFVA · VANGUARD WELLINGTON FUND | 0.09% | 4,336 SH | Aug. 19, 2026 | Daily |
| VFMF · VANGUARD WELLINGTON FUND | 0.08% | 3,482 SH | Aug. 19, 2026 | Daily |
| IWR · iShares Trust | 0.07% | 274,791 SH | Sept. 11, 2026 | Daily |
| XOEF · iShares Trust | 0.06% | 83 SH | Sept. 11, 2026 | Daily |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.04% | 424 NS | July 31, 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.04% | 15,374 SH | Aug. 19, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.04% | 1,211 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.04% | 4,965 NS | July 31, 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0.03% | 417 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.03% | 96,570 NS | July 31, 2026 | N-PORT |
| IVE · iShares Trust | 0.03% | 111,147 SH | Sept. 11, 2026 | Daily |
| IUSV · iShares Trust | 0.03% | 57,946 SH | Sept. 11, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.03% | 27,760 NS | July 31, 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.03% | 20,398 SH | Oct. 1, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 40,343 SH | Aug. 19, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.03% | 5,902 NS | July 31, 2026 | N-PORT |
| DSI · iShares Trust | 0.03% | 10,314 SH | Sept. 11, 2026 | Daily |
| IWD · iShares Trust | 0.03% | 148,444 SH | Sept. 11, 2026 | Daily |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.03% | 1,790 SH | Oct. 1, 2026 | Daily |
| TILT · FlexShares Trust | 0.03% | 3,318 NS | July 31, 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.02% | 7,120 SH | Oct. 1, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.02% | 15,866 NS | July 31, 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.02% | 13,488 SH | Oct. 1, 2026 | Daily |
| VOO · VANGUARD INDEX FUNDS | 0.02% | 1,729,431 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 2,161,771 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 10,952 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 5,657 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.02% | 15,119 SH | Aug. 19, 2026 | Daily |
| TOPC · iShares Trust | 0.02% | 40 SH | Sept. 11, 2026 | Daily |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.02% | 2,046 SH | Oct. 1, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.02% | 21,777 NS | July 31, 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.02% | 3,372 NS | July 31, 2026 | N-PORT |
| XVV · iShares Trust | 0.02% | 762 SH | Sept. 11, 2026 | Daily |
| SPUU · Direxion Shares ETF Trust | 0.02% | 251 NS | July 31, 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0.02% | 1,595 NS | July 31, 2026 | N-PORT |
| IVV · iShares Trust | 0.02% | 839,331 SH | Sept. 11, 2026 | Daily |
| PBP · Invesco Exchange-Traded Fund Trust | 0.01% | 393 SH | Oct. 1, 2026 | Daily |
| IWB · iShares Trust | 0.01% | 46,084 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.01% | 18,798 SH | Sept. 11, 2026 | Daily |
| IYY · iShares Trust | 0.01% | 2,819 SH | Sept. 11, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.01% | 464 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.01% | 87,429 SH | Sept. 11, 2026 | Daily |
| SPXL · Direxion Shares ETF Trust | 0.01% | 5,207 NS | July 31, 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0.01% | 53 SH | Oct. 1, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 58,076 SH | Aug. 19, 2026 | Daily |
| LGDX · Tidal Trust III | 0.01% | 71 NS | July 31, 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0.16% | -24,215 NS | July 31, 2026 | N-PORT |
| SLTY · Tidal Trust II | -2.76% | -3,000 NS | July 31, 2026 | N-PORT |
| ISCB · iShares Trust | · | 3,130 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 8,638 SH | Sept. 11, 2026 | Daily |
ALGN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
14 analysts · 2026-10-02Mean target $206.36 +43.6%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| MDLN | · | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
Latest News Recent headlines mentioning this company
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.